Increasing supplemental thyroid hormone use among premature infants born at 23 to 32 weeks' gestation

American Journal of Perinatology

Volumn 27, Issue 9, 2010, Pages 731-735

  Linn, Megan ^a   Yoder, Bradley A ^a   Clark, Reese H ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PEDIATRIX MEDICAL GROUP   (United States)

Author keywords

Hypothyroxinemia; premature infant; thyroid

Indexed keywords

LEVOTHYROXINE; THYROXINE;

ARTICLE; FREE THYROXINE INDEX; GESTATIONAL AGE; HUMAN; HYPOTHYROIDISM; NEWBORN; NEWBORN DISEASE; OVERALL SURVIVAL; PREMATURITY; PRIORITY JOURNAL; SUPPLEMENTATION; THYROID FUNCTION TEST; TRANSIENT HYPOTHYROXINEMIA OF PREMATURITY;

CHILD; CHILD, PRESCHOOL; CONGENITAL HYPOTHYROIDISM; DEVELOPMENTAL DISABILITIES; HORMONE REPLACEMENT THERAPY; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; NERVOUS SYSTEM DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; THYROXINE;

EID: 77956816034     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0030-1253556     Document Type: Article

References (25)

1. Fisher D A. Thyroid function and dysfunction in premature infants. Pediatr Endocrinol Rev 2007 4 317-328
2. Williams F L., Visser T J., Hume R. Transient hypothyroxinaemia in preterm infants. Early Hum Dev 2006 82 797-802
3. Den Ouden A L., Kok J H., Verkerk P H., Brand R, Verloove-Vanhorick S P. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996 39 142-145
4. Lucas A, Morley R, Fewtrell M S. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 1996 312 1132-1133 discussion 1133-1134
5. Reuss M L., Paneth N, Pinto-Martin J A., Lorenz J M., Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996 334 821-827
6. Morreale de Escobar G, Obregon M J., Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol 2004 151 (Suppl 3) U25-U37
7. Zoeller R T., Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 2004 16 809-818
8. Chowdhry P, Scanlon J W., Auerbach R, Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics 1984 73 301-305
9. Biswas S, Buffery J, Enoch H, Bland M, Markiewicz M, Walters D. Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trialthyroid hormone replacement in neonates. Pediatr Res 2003 53 48-56
10. van Wassenaer A G., Kok J H., de Vijlder J J. et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997 336 21-26
11. Amato M, Pasquier S, Carasso A, Von Muralt G. Postnatal thyroxine administration for idiopathic respiratory distress syndrome in preterm infants. Horm Res 1988 29 27-30
12. Vanhole C, Aerssens P, Naulaers G et al. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res 1997 42 87-92
13. Smith L M., Leake R D., Berman N, Villanueva S, Brasel J A. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. J Perinatol 2000 20 427-431
14. Valerio P G., van Wassenaer A G., de Vijlder J J., Kok J H. A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatr Res 2004 55 248-253
15. Osborn D A. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database Syst Rev 2001 (4) CD001070
16. Golombek S G., LaGamma E F., Paneth N. Treatment of transient hypothyroxinemia of prematurity: a survey of neonatal practice. J Perinatol 2002 22 563-565
17. Laughon M, Bose C, Clark R. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. J Perinatol 2007 27 164-170
18. Williams F L., Simpson J, Delahunty C et al, Collaboration from the Scottish Preterm Thyroid Group. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004 89 5314-5320
19. Rose S R., Brown R S., Foley T et al, American Academy of Pediatrics Section on Endocrinology and Committee on Genetics, American Thyroid Association Public Health Committee, Lawson Wilkins Pediatric Endocrine Society. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006 117 2290-2303
20. van Wassenaer A G., Briët J M., van Baar A et al. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics 2002 110 534-539
21. Briët J M., van Wassenaer A G., Dekker F W., de Vijlder J J., van Baar A, Kok J H. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001 107 712-718
22. Osborn D A., Hunt R W. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2007 (1) CD005948
23. Osborn D A., Hunt R W. Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database Syst Rev 2007 (1) CD005945
24. vanWassenaer A G., Kok J H. Thyroid function and thyroid hormone requirements of very preterm infants. Pediadtr Rev Neo Rev 2000 1 e116-e121
25. La Gamma E F., van Wassenaer A G., Golombek S G. et al. Neonatal thyroxine supplementation for transient hypothyroxinemia of prematurity: beneficial or detrimental? Treat Endocrinol 2006 5 335-346